Prevalence of Skin Diseases Accelerating the Dermatology Drugs Sector Growth
The human skin functionality
decreases with age, which leads to problems such as reduced subcutaneous fat,
slow healing, raised sensitivity to ultraviolet (UV) radiation, and increased
susceptibility to skin infections.
Hence, the growing geriatric population results
in the prevalence of skin diseases, such as intertrigo, as
atrophy, pruritus, and
candidiasis infection.
All of these are being increasingly cured with pharmaceutical products, which is
resulting in the growth of the dermatology drugs sector.
Further, the number
of people aged 80 or above is expected to rise massively during the forecast
period. The data for the geriatric population along with the rising prevalence of
skin diseases in the elderly predicts a heavy need for dermatological products.
Thus, the growing aging population and increasing prevalence of skin diseases are
driving the dermatology drugs sector across the globe.
